Atreca, Inc.

Atreca, Inc.

Atreca, Inc.

Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics.
Founded
2011
Raised
$308.8M
Follow us
Alexa global traffic share
20 Jun 2019
16 Sep 2018
$125,000,000
Venture capital (Series C)

Atreca Raises $125M in Series C Funding

FinSMEs
+2
17 Aug 2017
$35,000,000
Venture capital (Series B)
Cormorant Asset Management, Wellington Management Company

Atreca raises $35 mln Series B co-led by Wellington

PE HUB
+1
17 Aug 2017
$35,000,000
Venture capital (Series B)

Atreca Completes Oversubscribed $35 Million Series B Financing to Advance Novel Cancer Immunotherapies

businesswire
+1